ChemoCentryx Cash and Cash Equivalents 2011-2026 | CCXI

Annual Cash and Cash Equivalents ChemoCentryx

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
50 M	32.3 M	39.2 M	28.1 M	40 M	12 M	12.8 M	16.1 M	10.3 M	8.46 M	40.2 M	12.1 M	21.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
50 M	8.46 M	24.8 M

Quarterly Cash and Cash Equivalents ChemoCentryx

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	44.4 M	40.6 M	50 M	93.7 M	77.2 M	68.5 M	33.4 M	56.2 M	333 M	59.4 M	39.2 M	35.9 M	38.7 M	79.3 M	28.1 M	24.1 M	68.8 M	30.6 M	40 M	18 M	21.5 M	19 M	12 M	13.9 M	21.9 M	13.4 M	12.8 M	14.6 M	11.6 M	25.4 M	16.1 M	20.9 M	13.1 M	11.6 M	10.3 M	22.3 M	50.3 M	11.6 M	8.46 M	13.1 M	2.76 M	20.7 M	40.2 M	40.2 M	40.2 M	40.2 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
333 M	2.76 M	38.9 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	1.91 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	261 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	5.71 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	69.3 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	54 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	6.38 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	8.53 M	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	168 M	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	25.9 M	$ 35.0	1.6 %	$ 942 M	USA
Forte Biosciences FBRX	77 M	$ 22.0	8.32 %	$ 285 M	USA
Checkmate Pharmaceuticals CMPI	50.7 M	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	12.4 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	86.5 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	76.3 M	-	-	$ 344 M	USA
IMV IMV	21.2 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
BioNTech SE BNTX	7.68 B	$ 90.93	0.63 %	$ 22 B	Germany
Autolus Therapeutics plc AUTL	104 M	$ 1.65	1.85 %	$ 439 M	Britain
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Grifols, S.A. GRFS	980 M	$ 8.11	-0.98 %	$ 5.51 B	Spain
Cyclacel Pharmaceuticals CYCCP	3.5 M	-	-4.36 %	$ 27 M	USA
Heron Therapeutics HRTX	28.6 M	$ 0.87	3.09 %	$ 145 M	USA
Compugen Ltd. CGEN	90.6 M	$ 2.61	-3.51 %	$ 244 M	Israel
Anika Therapeutics ANIK	57.5 M	$ 15.02	-0.79 %	$ 215 M	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	7.31 M	-	5.93 %	$ 314 M	Canada
Incyte Corporation INCY	3.1 B	$ 97.41	0.34 %	$ 19 B	USA
Ionis Pharmaceuticals IONS	372 M	$ 75.78	0.96 %	$ 12.1 B	USA
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	5.53 M	$ 3.44	-0.58 %	$ 5.66 M	Israel
AIkido Pharma AIKI	34 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	935 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	88.9 M	$ 1.57	3.97 %	$ 184 M	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	98.1 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	17.8 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	42.9 M	$ 21.01	2.64 %	$ 2.67 B	USA
Allena Pharmaceuticals ALNA	30 M	-	3.16 %	$ 1.9 M	USA